1. The Crowd Is Betting a Quarter Billion Dollars on When America Bombs Iran
Forget the pundits. Forget the Pentagon briefings. If you want to know when the United States might strike Iran, ask the people putting real money on it.
Polymarket, the cryptocurrency-based prediction platform where anonymous traders wager on everything from elections to weather, now hosts a $289 million market on the question: "US strikes Iran by...?" As of Tuesday morning, traders give it a 36% chance by February 28 and 54% by March 15. The odds of a strike by March 31 surged 32% in a single week, according to Israel Hayom. This isn't a fringe bet. It's a quarter-billion-dollar consensus that American bombs may be falling on Iran within six weeks.
The market spiked after retired Maj. Gen. Amos Yadlin, former head of Israel's Military Intelligence Directorate, went on live television last Wednesday and said he'd "think twice about boarding a plane" this weekend. The ex-spy chief who once ran Israel's intelligence apparatus telling his country not to fly is not a subtle signal.
Here's where it gets truly wild: last week, Israeli prosecutors indicted two people for using classified military intelligence to place Polymarket bets on strikes against Iran. A civilian and a military reservist allegedly turned inside knowledge of the June 2025 Israel-Iran war into winning wagers. It was the first known criminal case anywhere in the world involving insider trading on armed conflict. In January, a separate Polymarket trader flipped $32,000 into $400,000 by correctly predicting the U.S. would topple Venezuelan leader Nicolas Maduro before the operation went public. Nobody has been charged in that case.
Polymarket operates offshore, outside U.S. regulatory reach, with anonymous crypto wallets. Kalshi, its U.S.-regulated competitor, is banned by the CFTC from offering bets on wars, terrorism, and assassinations. Polymarket faces no such restriction. As Stanford law professor and former SEC Commissioner Joseph Grundfest told NPR: "Such bets can put your own military at greater risk because you are signaling to your enemies what may happen, and that puts your own troops in danger."
Meanwhile, two carrier strike groups sit in the Persian Gulf running up a $12 million daily tab for American taxpayers. Iran's nuclear talks produced "guiding principles" but no deal. Trump gave Tehran roughly a month to agree. That month is almost up. And a quarter billion dollars says the bombs are next.
Sources: Polymarket, Israel Hayom, VINnews, NPR, Times of Israel
2. "Zero Knowledge" Turns Out to Mean "We Know Everything"
If you use Bitwarden, LastPass, or Dashlane, congratulations: you're among the roughly 94 million American adults who trust a password manager with the keys to their digital life (per Security.org's 2025 survey). You were told your vault was encrypted on your device, that nobody at the company could read it, and that even a server breach couldn't touch you. Researchers at ETH Zurich just found 25 ways that's not true.
Turns out "zero knowledge" was more of a marketing aspiration than an engineering achievement.
The most devastating attacks target Bitwarden and LastPass and would let an attacker who compromises the server read or write the contents of entire vaults: every password, every credit card number, every "secure note" where you stored that crypto seed phrase. Not some exotic theoretical hack, either. The researchers describe the flaws as "numerous but mostly not deep in a technical sense." They sat in plain sight for over a decade, through multiple professional security audits that apparently audited everything except the parts that mattered. One might ask what those auditors were actually auditing.
The culprits are key escrow mechanisms (the systems that let you recover your account when you forget your master password) and legacy software compatibility. In other words, the features marketed as conveniences are the ones that blow the vault door off its hinges. A separate attack against Dashlane allowed reading shared vault items.
All three companies were given 90 days' notice and have begun patching, but some weaknesses are architectural, baked into the product design rather than fixable with a quick update. Fixing them may require redesigning features millions of people rely on, like account recovery and vault sharing. So: good luck with that.
What to do: Most attacks require specific features to be enabled (account recovery, vault sharing, group memberships). Check whether you've turned those on. If your threat model is serious, consider a locally stored vault. 1Password wasn't fully analyzed in the study, which at this point is less reassuring than it sounds.
Sources: Ars Technica, The Hacker News, CyberInsider, Help Net Security, ETH Zurich Paper
3. The President's Son Invested in Prediction Markets. Now Dad's Regulator Is Overriding State Gambling Laws to Protect Them.
The Trump administration's newly appointed CFTC chairman, Michael Selig, announced this week that the federal government will intervene on behalf of prediction market companies Kalshi and Polymarket in their legal battles against state gambling regulators. His position: the CFTC has "exclusive jurisdiction" over these platforms, and states can't touch them.
Small problem: Donald Trump Jr. has invested in Polymarket through his venture capital firm and serves as a strategic advisor to Kalshi.
Prediction markets let users wager on anything from "Will it rain in LA tomorrow?" to "Who wins the NBA Finals?" Companies like Kalshi and Polymarket classify their products as "event derivatives" (futures contracts, legally speaking), which puts them under federal commodities law rather than state gaming commissions. That means they can operate in all 50 states, including those where gambling is illegal, and accept users as young as 18 (state gambling typically requires 21).
The numbers make the "not gambling" defense hard to maintain. About 90% of Kalshi's trading volume is on sports, per the company's own data as reported by Newsweek. Kalshi says it processed over $1 billion in Super Bowl wagers alone, per the Nevada Independent. At least 20 federal lawsuits have been filed by states arguing these platforms are unlicensed sports betting operations, per The Guardian. Nevada's gaming board got a temporary restraining order against Kalshi. Massachusetts obtained a preliminary injunction.
At his confirmation hearing, Selig said the courts should decide. Now he's filing friend-of-the-court briefs and created a 35-member "Innovation Advisory Committee" that includes the CEOs of Polymarket, Kalshi, Coinbase, Robinhood, FanDuel, and DraftKings. Consumer advocates or public interest groups? Zero representation.
"To those who seek to challenge our authority in this space, let me be clear, we will see you in court," Selig wrote in the Wall Street Journal.
The federalism angle matters regardless of how you feel about gambling. State gaming laws exist because states chose to regulate (or ban) gambling within their borders. Federal preemption of state gambling authority is an expansion of federal power, not a reduction. And when the federal regulator's position happens to protect the president's family's investments, the conflict of interest writes itself.
Sources: AP News, The Guardian, PBS
4. The Air Force Blew $1.79 Million on Combat Switchblades and Called Them Box Cutters
For nearly a decade, Air Force maintenance units spent $1.79 million in taxpayer funds buying 5,166 high-end combat knives, mostly Benchmade Infidels (sleek automatic switchblades that retail for several hundred dollars each), through the military supply system. They called them "box cutters."
Everyone on the flight line knew the knives had zero legitimate maintenance use. The Benchmade Infidel is a front-opening automatic blade designed and marketed for combat. Its presence around aircraft mechanics is "difficult to justify, and often outright banned," per The Intercept's investigation, which obtained procurement records from 12 Air Force bases via FOIA. Every single base that returned records showed the same pattern.
The knives served as welcome gifts, favors, and informal currency. "Tech sergeants would come in for a short time and get a knife as a welcome present," one former maintainer from Hill Air Force Base said. Another: "If you wanted one, all you had to do was be friends with people attached to the supply line." At Moody Air Force Base in Georgia, documents noted a "recurring problem with physical location and quantity consistency" and acknowledged that "thievery is not out of question."
Meanwhile, maintainers at the same bases reported chronic shortages of safety wire, specialized hydraulic fluids, and calibrated test equipment, the tools they actually need to keep planes flying. "Jets would come back with the same broken parts or worse, just so we could meet flight numbers," said a senior airman from Nellis. "We never had money for proper tools."
It's $1.79 million. In a $300 billion Air Force budget, it's a rounding error. But it illustrates exactly how federal procurement works in practice: high-end luxuries slide through the supply system on handshakes while essential tools get stuck in bureaucratic limbo. Multiply this across every branch, every base, every department, and you start to understand where the trillion-dollar “defense” budget actually goes.
Sources: The Intercept
5. Magic Mushrooms Cleared Every Clinical Hurdle. Now They Face Something Harder: the FDA.
For half a century, the federal government classified psilocybin alongside heroin, raided labs, and put people in cages for growing mushrooms in their basements. On Tuesday, a UK pharmaceutical company announced that the stuff actually works as medicine, and the clinical data to prove it is now complete.
Compass Pathways' synthetic psilocybin treatment, COMP360, hit the primary endpoint in its second Phase 3 trial for treatment-resistant depression, the last major clinical hurdle before the FDA decides whether to approve it. Treatment-resistant depression affects an estimated 2.8 million Americans (per a study in the Journal of Clinical Psychiatry) who don't respond to existing antidepressants. COMP360 is a single dose administered in a supervised setting. If approved, it would be the first psilocybin-based medicine ever to receive FDA authorization.
The timing is exquisite. FDA Commissioner Marty Makary, the Johns Hopkins surgeon who built his reputation criticizing medical establishment groupthink, spent last week getting grilled by pharma executives at an industry forum over the agency's recent vaccine decisions. He's now the guy who decides whether the government approves a drug it spent 50 years demonizing. Meanwhile, CMS chief Mehmet Oz (yes, the TV doctor who once told millions of viewers that green coffee extract was a "miracle fat burner") got a warmer reception from the same pharma crowd. Oz oversees $1.5 trillion in annual Medicare and Medicaid spending. The man who hawked raspberry ketones is cozier with the pharmaceutical industry than the actual FDA commissioner. This is the regulatory environment psilocybin walks into.
Compass stock surged on the news, though more detailed safety data is still needed. The company expects to file for FDA approval in the coming months.
The question: will the FDA treat psilocybin like any other drug that clears clinical trials? Or will the cultural baggage of "magic mushrooms" create obstacles that synthetic opioids and amphetamines, both Schedule II drugs with catastrophically worse safety profiles, never faced? Fentanyl analogs get fast-tracked. Adderall is prescribed to children. Psilocybin cured depression in two Phase 3 trials. The data is in. The politics are what's left.
Sources: STAT News, Yahoo Finance, Psychiatric Times